Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is evaluating a 58-year-old man with
newly diagnosed hypertension. Before initiating pharmacotherapy, the
APRN reviews the patient's medical history, current medications,
laboratory results, and lifestyle factors. Which action best reflects the
APRN's role as a safe and effective prescriber?
A. Prescribe the medication preferred by the patient without further
assessment.
B. Select the medication with the lowest acquisition cost regardless of
patient-specific factors.
C. Integrate clinical evidence, patient-specific characteristics, and
shared decision-making before selecting therapy.
D. Delay treatment until the patient independently researches
medication options.
Correct Answer: C
Rationale:
Evidence-based prescribing requires integrating the best available
clinical evidence with the patient's comorbidities, concurrent
medications, preferences, laboratory data, and treatment goals. Shared
decision-making promotes adherence and improves therapeutic
outcomes. Option A overlooks essential clinical assessment. Option B
ignores individualized care. Option D unnecessarily delays appropriate
treatment and fails to meet the APRN's responsibility for timely clinical
management.
Question 2
,A newly licensed APRN is preparing to prescribe controlled substances
in an outpatient clinic. Which action is most appropriate before
independently prescribing Schedule II through V medications?
A. Begin prescribing under the supervising physician's DEA registration.
B. Obtain the required state prescriptive authority and a personal DEA
registration if authorized by state law.
C. Prescribe controlled substances only after six months of clinical
practice.
D. Use another APRN's DEA number until individual registration is
completed.
Correct Answer: B
Rationale:
APRNs must comply with applicable federal and state regulations
governing controlled substance prescribing. Where permitted, this
includes obtaining state prescriptive authority and an individual DEA
registration before prescribing controlled medications. Option A
violates federal requirements. Option C is not a legal prerequisite.
Option D is unlawful because DEA registrations are not transferable.
Question 3
A patient asks an APRN why additional questions are necessary before
receiving a refill for a medication that has worked well for several years.
Which response best demonstrates the principles of responsible
prescribing?
A. "Because insurance companies require additional documentation."
, B. "I need to ensure the medication remains effective, safe, and
appropriate based on your current health status."
C. "Medication refills always require repeating the original diagnosis."
D. "Refills are mainly intended to update your medical record."
Correct Answer: B
Rationale:
Responsible prescribing is an ongoing process that includes evaluating
therapeutic effectiveness, adverse effects, new contraindications,
medication adherence, drug interactions, and changes in the patient's
health. Regular reassessment helps optimize outcomes and minimize
harm. Options A, C, and D identify administrative or incomplete reasons
rather than the primary clinical purpose of reassessment.
Question 4
An APRN is considering treatment options for a 74-year-old woman
with chronic kidney disease who takes multiple medications. Which
prescribing approach best minimizes medication-related harm?
A. Initiate several new medications simultaneously to achieve
treatment goals quickly.
B. Prescribe standard adult doses because age alone does not affect
pharmacotherapy.
C. Review renal function, assess for potential drug interactions, and
individualize medication selection and dosing.
D. Continue adding medications until symptoms resolve without
reassessing the regimen.
Correct Answer: C
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is evaluating a 58-year-old man with
newly diagnosed hypertension. Before initiating pharmacotherapy, the
APRN reviews the patient's medical history, current medications,
laboratory results, and lifestyle factors. Which action best reflects the
APRN's role as a safe and effective prescriber?
A. Prescribe the medication preferred by the patient without further
assessment.
B. Select the medication with the lowest acquisition cost regardless of
patient-specific factors.
C. Integrate clinical evidence, patient-specific characteristics, and
shared decision-making before selecting therapy.
D. Delay treatment until the patient independently researches
medication options.
Correct Answer: C
Rationale:
Evidence-based prescribing requires integrating the best available
clinical evidence with the patient's comorbidities, concurrent
medications, preferences, laboratory data, and treatment goals. Shared
decision-making promotes adherence and improves therapeutic
outcomes. Option A overlooks essential clinical assessment. Option B
ignores individualized care. Option D unnecessarily delays appropriate
treatment and fails to meet the APRN's responsibility for timely clinical
management.
Question 2
,A newly licensed APRN is preparing to prescribe controlled substances
in an outpatient clinic. Which action is most appropriate before
independently prescribing Schedule II through V medications?
A. Begin prescribing under the supervising physician's DEA registration.
B. Obtain the required state prescriptive authority and a personal DEA
registration if authorized by state law.
C. Prescribe controlled substances only after six months of clinical
practice.
D. Use another APRN's DEA number until individual registration is
completed.
Correct Answer: B
Rationale:
APRNs must comply with applicable federal and state regulations
governing controlled substance prescribing. Where permitted, this
includes obtaining state prescriptive authority and an individual DEA
registration before prescribing controlled medications. Option A
violates federal requirements. Option C is not a legal prerequisite.
Option D is unlawful because DEA registrations are not transferable.
Question 3
A patient asks an APRN why additional questions are necessary before
receiving a refill for a medication that has worked well for several years.
Which response best demonstrates the principles of responsible
prescribing?
A. "Because insurance companies require additional documentation."
, B. "I need to ensure the medication remains effective, safe, and
appropriate based on your current health status."
C. "Medication refills always require repeating the original diagnosis."
D. "Refills are mainly intended to update your medical record."
Correct Answer: B
Rationale:
Responsible prescribing is an ongoing process that includes evaluating
therapeutic effectiveness, adverse effects, new contraindications,
medication adherence, drug interactions, and changes in the patient's
health. Regular reassessment helps optimize outcomes and minimize
harm. Options A, C, and D identify administrative or incomplete reasons
rather than the primary clinical purpose of reassessment.
Question 4
An APRN is considering treatment options for a 74-year-old woman
with chronic kidney disease who takes multiple medications. Which
prescribing approach best minimizes medication-related harm?
A. Initiate several new medications simultaneously to achieve
treatment goals quickly.
B. Prescribe standard adult doses because age alone does not affect
pharmacotherapy.
C. Review renal function, assess for potential drug interactions, and
individualize medication selection and dosing.
D. Continue adding medications until symptoms resolve without
reassessing the regimen.
Correct Answer: C
